Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Ann Surg Oncol. 2019 Jan 9;26(3):782–790. doi: 10.1245/s10434-018-07150-5

Table 4:

Clinical Characteristics for High-Magnitude Casesb, based on Recovery Protocol

Factor Total
n=1022
Traditional
n=651 (64)
Enhanced
Recovery
n=371 (36)
p value

Superficial incisional SSI 51 (5) 36 (6) 15 (4) 0.294
Deep incisional SSI 10 (1) 8 (1) 2 (0.54) 0.281
Organ space infection 61 (6) 38 (6) 23 (6) 0.814
Wound disruption/dehiscence 24 (2) 16 (2) 8 (2) 0.760
Pneumonia 29 (3) 19 (3) 10 (3) 0.836
Mechanical ventilation >48 hrs 8 (1) 6 (1) 2 (1) 0.718
Urinary tract infection 48 (5) 35 (5) 13 (4) 0.174
Transfusion ≤72 hrs of OR 305 (30) 214 (33) 91 (25) 0.005
Sepsis 24 (2) 17 (3) 7 (2) 0.462
Unplanned return to OR 45 (4) 31 (5) 24 (5) 0.459
Any complication 416 (41) 288 (44) 128 (35) 0.002
 Any severe complicationa 136 (13) 90 (14) 46 (12) 0.519
LOS, days, median (IQR) 6 (4–8) 6 (5–8) 5 (3–7) <0.0001
Mortality ≤30 days 3 (0.29) 3 (0.46) 0 (0) 0.558
Readmission ≤30 days 130 (13) 78 (12) 52 (14) 0.348

SSI: surgical site infection; OR: operating room; IQR: interquartile range; LOS: length of stay

b

Defined as RVU >30

a

Severe complications include: organ space infection, wound disruption/dehiscence, pneumonia, unplanned intubation, acute renal failure, myocardial infarction, sepsis, septic shock, unplanned return to OR